Download - 510k Submission Overview
![Page 1: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/1.jpg)
Novartis Flu KitRegulatory Discussion
PresenterOctober XX, 2010
510k Submission OverviewMyraqa, Inc.August 22, 2012
![Page 2: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/2.jpg)
About Myraqa, Inc.
• Myraqa is the leading IVD consulting firm
• Headquarters in Silicon Valley• Clients include IVD
manufacturers, pharma, clinical labs, investors and other industry stakeholders
2
![Page 3: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/3.jpg)
About Myraqa, Inc.• Team-Driven Success
» We employ leading experts in IVD Regulatory, Quality, Clinical, Biostatistics, Development and Marketing
» Team approach best combines diverse expertise» Team members are employees, not contractors» All senior staff have at least 15 years of relevant
experience, most have considerably more
3
![Page 4: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/4.jpg)
What is a 510(k)?
• Premarket Notification• Section 510(k) of Federal Food, Drug, & Cosmetic
Act• 21 CFR 807 Subpart E• Marketing Clearance Application• Allows FDA to Determine Substantial Equivalence
(SE)• Classification process for a device
4
![Page 5: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/5.jpg)
What a 510(k) Is Not
• A Form• Establishment Registration• Device Listing• Premarket Approval (PMA)
5
![Page 6: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/6.jpg)
What is a Predicate?• An identification of the legally marketed device to
which the submitter claims equivalence. A legally marketed device to which a new device may be compared for a determination regarding substantial equivalence is: » a device that was legally marketed prior to May 28,
1976, » or a device which has been reclassified from class III to
class II or I (the predicate),» or a device which has been found to be substantially
equivalent through the 510(k) process;
6
![Page 7: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/7.jpg)
Regulatory Classes for Devices
Three Regulatory Classes (level of control based on risk):
• Class I – General Controls• Class II – General Controls, Special Controls and
Premarket Notification• Class III – General Controls and Premarket
Approval
7
![Page 8: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/8.jpg)
General Controls• Class I devices are subject to the least regulatory control
and are subject to “General Controls”• General controls include:
» Establishment Registration of companies which are required to register under 21 CFR 807.20, such as manufacturers, distributers, repackages and relabelers
» Medical Device Listing with FDA of devices to be marketed» Manufacturing devices in accordance with current Good
Manufacturing Practices (Quality System Regulation in 21 CFR 820)
» Labeling devices in accordance with labeling regulations in 21 CFR 801 or 908
» Submission of a premarket notification [510(k)] before marketing a device
8
![Page 9: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/9.jpg)
Special Controls
• May include special labeling requirements, mandatory performance standards and post-market surveillance
9
![Page 10: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/10.jpg)
510(k) Submission Required When?
• Introducing a device to the U.S. market for the first time
• Change in indications for use for a previously cleared device
• Making significant modification to a previously cleared device
10
![Page 11: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/11.jpg)
Who Must Submit a 510(k)?• Device Manufacturers• Specifications Developers• Repackagers who change device or its labeling• Relabelers who change the labeling- e.g., instructions
for use• Anyone who both manufactures & distributes• A company that distributes devices but does not
perform any of the other functions above is not required to submit a 510(k)
11
![Page 12: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/12.jpg)
Intended Use Statement
• FDA generally regulates devices according to the intended use – not the technology used to generate the information
• Intended use statement– includes a general description of diseases or conditions
that the device will diagnose, treat, prevent, cure, or mitigate including a description, where appropriate of the patient population for which the device intended (21 CFR Part 812.2)
12
![Page 13: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/13.jpg)
Systems Approach
• FDA takes a ‘systems approach’ to the regulation of devices and IVDs– Reagents, instruments, software – everything that is
needed to produce a diagnostic result must be included– Can utilize a partnership approach with parallel
submissions• Examples
– Affymetrix/Roche– CDC/Applied Biosystems
13
![Page 14: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/14.jpg)
Device Classifications• There are three classifications of devices
» Class I: Low Risk» Often 510(k) Exempt» General Controls
» Examples: General purpose reagents, Mass spectrometers» Class II: Moderate Risk
» Require 510(k) clearance before commercialization» General Controls + Special Controls (e.g., clinical testing)
» Class III: High Risk» Require Premarket Approval (PMA)» PMA inspection
![Page 15: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/15.jpg)
Contents of a 510(k)• Medical Device User Fee Cover Sheet• CDRH Premarket Review Submission Cover Sheet• Cover Letter• Intended Use / Indications for Use• 510(k) Summary• Truthful and Accurate Statement• Financial Certification or Disclosure Statements• Executive Summary
![Page 16: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/16.jpg)
Contents of a 510(k) (Cont)• Device Description
» Include all reagents and instruments used» This is where we give FDA the details on how our product works
• Proposed Labeling» Will include Package Insert or Operator’s Manual (Instructions for
Use)» Kit and component labeling
• Stability» Studies conducted and results (Real-Time)
• Software» Requirements outlined in Software Guidance document
![Page 17: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/17.jpg)
Contents of a 510(k) (Cont)• Performance Testing
» Analytical/bench testing – Often multiple studies» Animal testing (if required)» Clinical testing –external clinical sites (typically 3 site minimum)
» Approximately 10% of all 510(k)s» Important difference with the predicate device, e.g., new indication
for use or new technology» Must be collected under Investigational Device Exemption
Regulations (21 CFR Part 812)
17
![Page 18: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/18.jpg)
FDA 510(k) Review• FDA recently published Refuse to Accept Policy for 510(k)s, which
also includes administrative checklists for Traditional, Abbreviated and Special 510(k)s.
• Administrative Review» Administrative review will be completed within 15 days of receipt of 510(k) » Assessment of completeness of 510(k) not the quality of information
• The submitter will be notified in writing if the 510(k) was found administratively complete or incomplete. » If incomplete submitter has 30 days to respond to the RTA letter
» either provide the missing information or» request an extension request for up to 180 days from the date of the RTA
letter.» If complete FDA staff can begin the substantive
18
![Page 19: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/19.jpg)
FDA 510(k) Review• Substantive Review
» Review of content and quality of information submitted » FDA may request additional information/performance data to determine
substantial equivalence to the predicate» Reviewer requests by telephone, email or formal letter (from Doc
Center)» Clock stops by letter only» Submit additional information to Document Mail Center» 30 days to submit» May request an extension within 30 days of the request for additional
information» The request for extension should state the reason and time needed» The 510(k) may be deleted from the 510(k) tracking system if there is no
response to the request for additional information within 30 days of FDA’s request letter
19
![Page 20: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/20.jpg)
Substantial Equivalence (SE)Device is Substantially Equivalent to predicate if:
» Has the same intended use, and» Has the same technological characteristics as the
predicate device,• Or
» Has the same intended use, and» Has different technological characteristics and the
information in the 510(k): » Does not raise new questions of safety and effectiveness,
and» Demonstrates new device at least as safe and effective as
the predicate
20
![Page 21: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/21.jpg)
Not Substantially Equivalent (NSE)• There is no predicate device• Has a NEW intended use• Has different technological characteristics
compared to the predicate device and raises a new questions regarding safety and effectiveness » The NSE determination did not include data review and
will require PMA or De Novo
21
![Page 22: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/22.jpg)
Not Substantially Equivalent (NSE) (Cont)
• Does not demonstrate device is at least as safe and effective as the predicate » The NSE determination included data review and is
eligible for a new 510(k) with new data
• Approximately 3% are found NSE• Data is looked at last in the 510(k) regulatory
review process• FDA usually asks for additional information at
least once prior to determining the device is NSE for lack of data
22
![Page 23: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/23.jpg)
Key Take-Aways
• Review relevant FDA guidance documents and search the releasable 510(k) database» 510(k) summaries and decision summaries for similar
products• Use new RTA Checklist • Confirm regulatory pathway with FDA
» Pre-IDE or Pre-Submission Meetings
23
![Page 24: 510k Submission Overview](https://reader035.vdocument.in/reader035/viewer/2022062218/56816764550346895ddc42f2/html5/thumbnails/24.jpg)
Thank You
24